Boston Scientific Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Boston Scientific Corp 公司

波士顿科学公司是一家全球医疗器械开发商、制造商和营销商，其产品用于一系列介入医学专业。其 MedSurg 部门包括内窥镜检查、泌尿科和神经调节。其内窥镜业务开发和制造用于诊断和治疗各种胃肠道 (GI) 和肺部疾病的设备，采用微创技术。其泌尿科业务开发和制造用于治疗男性和女性各种泌尿系统疾病的设备。其神经调节业务开发和制造用于治疗各种神经运动障碍和控制慢性疼痛的设备。其心血管部门包括心脏病学和外周介入。其介入心脏病学治疗业务开发和制造用于诊断和治疗冠状动脉疾病和主动脉瓣疾病的技术。该公司还拥有经颈动脉血运重建 (TCAR) 平台。

公司简介

公司代码BSX

公司名称Boston Scientific Corp

上市日期May 19, 1992

成立日期1979

CEOMr. Michael F. (Mike) Mahoney

员工数量53000

证券类型Ordinary Share

年结日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NYSE Consolidated

国家United States of America

邮编01752-1234

电话15086834000

网址https://www.bostonscientific.com/en-US/Home.html

公司代码BSX

上市日期May 19, 1992

成立日期1979

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

37.98K

+5.88%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

4.98K

+71.73%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

Ms. Meghan Scanlon

Senior Vice President and President - Urology

--

名称

名称/职务

职务

持股

持股变动

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

37.98K

+5.88%

Ms. Ellen M. Zane

Independent Director

37.02K

+5.96%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

Other

1.27B

27.32%

地区USD

名称

营收

占比

United States

2.96B

63.48%

EMEA (Europe, Middle East and Africa)

846.00M

18.14%

Asia Pacific

701.00M

15.03%

Latin America and Canada

155.00M

3.32%

业务

地区

业务USD

名称

营收

占比

Electrophysiology

730.00M

15.66%

Interventional Cardiology Therapies

697.00M

14.95%

Endoscopy

673.00M

14.43%

Peripheral Interventions

656.00M

14.07%

Urology

633.00M

13.57%

Other

1.27B

27.32%

股东统计

更新时间: 5月14日周三

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.05%

Fidelity Management & Research Company LLC

7.94%

BlackRock Institutional Trust Company, N.A.

5.26%

State Street Global Advisors (US)

4.36%

PRIMECAP Management Company

2.47%

Other

70.92%

持股股东

占比

The Vanguard Group, Inc.

9.05%

Fidelity Management & Research Company LLC

7.94%

BlackRock Institutional Trust Company, N.A.

5.26%

State Street Global Advisors (US)

4.36%

PRIMECAP Management Company

2.47%

Other

70.92%

股东类型

持股股东

占比

Investment Advisor

43.49%

Investment Advisor/Hedge Fund

37.01%

Hedge Fund

3.98%

Pension Fund

2.86%

Research Firm

2.45%

Bank and Trust

1.71%

Sovereign Wealth Fund

1.54%

Private Equity

0.20%

Insurance Company

0.19%

Other

6.56%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

2690

1.38B

93.52%

-4.76M

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

2023Q1

2012

1.36B

94.85%

-23.81M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

133.95M

9.05%

+1.70M

+1.28%

Mar 31, 2025

Fidelity Management & Research Company LLC

117.45M

7.94%

-3.75M

-3.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

77.81M

5.26%

+1.08M

+1.41%

Mar 31, 2025

State Street Global Advisors (US)

64.48M

4.36%

+514.79K

+0.80%

Mar 31, 2025

PRIMECAP Management Company

36.50M

2.47%

-432.72K

-1.17%

Mar 31, 2025

Wellington Management Company, LLP

33.20M

2.24%

-2.97M

-8.21%

Mar 31, 2025

Geode Capital Management, L.L.C.

31.80M

2.15%

+1.18M

+3.84%

Mar 31, 2025

Capital World Investors

28.56M

1.93%

+658.82K

+2.36%

Mar 31, 2025

Managed Account Advisors LLC

21.29M

1.44%

+3.60M

+20.36%

Mar 31, 2025

The Bollard Group, LLC

20.49M

1.39%

-242.40K

-1.17%

Mar 31, 2025

持股ETF

更新时间: 7月6日周日

机构名称

占比

iShares U.S. Medical Devices ETF

11.13%

Goldman Sachs Future Health Care Equity ETF

8.57%

NYLI Healthy Hearts ETF

5.52%

iShares Health Innovation Active ETF

4.66%

Invesco Dorsey Wright Healthcare Momentum ETF

4.09%

JPMorgan Healthcare Leaders ETF

4.07%

Tema Heart & Health ETF

3.42%

Health Care Select Sector SPDR Fund

3.23%

Congress Large Cap Growth ETF

3.2%

Global X Aging Population ETF

3.18%

iShares U.S. Medical Devices ETF

占比11.13%

Goldman Sachs Future Health Care Equity ETF

占比8.57%

NYLI Healthy Hearts ETF

占比5.52%

iShares Health Innovation Active ETF

占比4.66%

Invesco Dorsey Wright Healthcare Momentum ETF

占比4.09%

JPMorgan Healthcare Leaders ETF

占比4.07%

Tema Heart & Health ETF

占比3.42%

Health Care Select Sector SPDR Fund

占比3.23%

Congress Large Cap Growth ETF

占比3.2%

Global X Aging Population ETF

占比3.18%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

波士顿科学

103.640USD

波士顿科学

103.640

概览

公司

财务